Navigation Links
Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
Date:8/27/2007

San Diego Dermatologist Promoting Regular Skin Examinations

SAN DIEGO, Aug. 27 /PRNewswire/ -- Once every ninety minutes a California resident is diagnosed with a new case of melanoma skin cancer, according to the American Cancer Society. A local dermatologist is working to decrease this alarming statistic, and increase the likelihood that local residents diagnosed with this deadliest type of skin cancer will survive.

"Avoiding excessive exposure to direct sunlight and protecting your skin from harmful ultraviolet rays is the best defense against skin cancer, but it's equally important to have your skin examined at least once a year by a board-certified dermatologist, especially if you have any moles that are irregular in shape or have recently appeared or changed in size, shape or color," said Dr. Kenneth Gross of Skin Surgery Medical Group. "Early detection of suspicious pigmented lesions is the key to early diagnosis and the prevention of advanced melanoma."

When melanoma is caught in its early stages, it's almost always curable.

Risk factors for melanoma include:

* Sunburns

* Presence of many moles and/or large moles (>6mm)

* Fair skin, freckling, light eyes, or natural red or blond hair

* Family history of melanoma

* Past personal history of melanoma

Traditionally, dermatologists have relied on their own eyes and judgment in deciding whether to remove a suspicious mole.

Skin Surgery Medical Group is participating in a nationwide patient trial to test an investigational medical technology called MelaFind(R), designed to assist physicians in the early diagnosis of melanoma.

MelaFind is a non-invasive hand-held imaging device that emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions (moles). MelaFind then analyzes the images in order to provide information to the physician and produce a recommendation of whether the lesion should be biopsied.

"We encourage patients to come in for skin exams in general, especially during the summer months when people tend to spend a lot of time outdoors in the sun," said Dr. Gross.

If you think you have a mole that may be cancerous, and would like to have it examined, please contact Skin Surgery Medical Group at 858-292-8641. You may also be eligible to participate in the MelaFind trial.

About Skin Surgery Medical Group, Inc.

At Skin Surgery Medical Group physicians and staff are dedicated to providing its patients with the best possible skin care. Dr. Gross at Skin Surgery Medical Group specializes in the following: skin cancer diagnosis and treatment including but not limited to melanoma, basal cell cancer, squamous cell cancer; diagnosis and treatment of moles and melanoma including sentinel node biopsy of lymph nodes; Mohs Surgery of skin cancer; evaluation and treatment of dysplastic nevus syndrome including use of episope evaluation of moles; skin flaps; skin grafts (full thickness and split thickness); cryosurgery for precancer and cancer; skin cancer surgery of lips, nails, ears, eyelids, and scalp; interferon for cancer, warts, and other skin problems. For more information visit http://www.skinsurgerymed.com.

Media Contact:

Erich Sandoval, Lazar Partners

Tel: (212) 867-1762

esandoval@lazarpartners.com


'/>"/>
SOURCE Skin Surgery Medical Group
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Prospective Model Outlined Potential Time and Cost Savings of Once-Monthly Anemia Treatment
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
6. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
7. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
8. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
9. CuraGen Presents Update on Clinical Development Program for Belinostat
10. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
11. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 The global  pacemaker market  is expected to ... View Research, Inc. The heightening prevalence of cardiac conditions coupled with the availability ... globally. In addition, technological enhancements in these devices are supporting the expansion of ... ... Grand View Research Logo ...
(Date:1/19/2017)... , Jan. 18, 2017  ViewRay, Inc. ... world,s first and only clinical MRI-guided radiation therapy ... proceeds of approximately $26.1 million through a private ... Capital Management led the financing and was joined ... Advisors, LLC and Kearny Venture Partners, and an ...
(Date:1/19/2017)... 2017  Magnetic Insight Inc., leader in magnetic ... agreement with inviCRO LLC to develop intuitive image ... based on inviCRO,s VivoQuant™ visualization and post processing ... complete MPI solution package with the Momentum MPI ... imaging in vivo. MPI is a ...
Breaking Medicine Technology:
(Date:1/19/2017)... PETALUMA, CA (PRWEB) , ... January 19, 2017 ... ... new Tranquility acoustic and privacy panel system. , The Tranquility privacy panel ... to a collaborative office environment. Tranquility panels help reduce noise and provide the ...
(Date:1/19/2017)... Ashland, VA (PRWEB) , ... January 19, 2017 , ... ... planning services to the eastern Virginia region, is inaugurating a charity event to honor ... community. , While on duty last year, Chad Phillip Dermyer and his fellow officers ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... Reproductive Endocrinologists at Reproductive Medicine Associates of Connecticut (RMACT) have earned “Top ... Cynthia Murdock and Dr. Shaun Williams have each been chosen by their peers ...
(Date:1/19/2017)... ... ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today that ... 20 years SFI has been recognized as the world’s leader in Intelligent Sales Outsourcing ... US market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, Ariello, ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... lines and wrinkles. Few people know that popular cosmetic fillers can ... Buckley, who is medical director of the MilfordMD Cosmetic Dermatology Surgery & Laser ...
Breaking Medicine News(10 mins):